MEF2D regulates T-cell function via CD70-CD27 signaling and promotes immune evasion in hepatocellular carcinoma
The Journal of Immunology · 2025
DOI: 10.1093/jimmun/vkaf228 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2025. Verfasst von Fanhua Kong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, National Quali…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, CD27 Ligand, MEF2 Transcription Factors. Die Arbeit nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) stands as one of the most prevalent and fatal malignancies globally, posing a persistent challenge in its treatment due to immune evasion. We knocked down MEF2D in HCC cell lines and analyzed HCC tissues and cell lines by RNA sequencing, Western blot, and immunohistochemistry. Chromatin immunoprecipitation was used to analyze the regulation of CD70 transcription by MEF2D. HCC cells with or without MEF2D knockout were injected into the livers of syngeneic BALB/c mice. Flow cytometry was used to analyze the function of T cells in tumors, spleens, and lymph nodes. We found that in contrast to wild-type tumors in immunocompetent mice, HCC with MEF2D knockdown had smaller tumors, increased T-cell activation, and impaired T regulatory (Treg) cell suppressive function. Mechanistically, MEF2D bound to the promoter region of CD70 gene and activated its transcription and this process was further enhanced by p300-induced MEF2D acetylation. CD70 blocking antibody inhibited activation of the CD70-CD27 signaling axis in murine HCC tumors, leading to impaired immunosuppressive function of Tregs and enhanced antitumor immunity. MEF2D blocks T-cell–mediated antitumor immunity by regulating the expression of CD70 and activating the CD70-CD27 signaling axis. Strategies to manipulate this pathway may improve the efficacy of liver cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, National Quality Control Center for Donated Organ Procurement, Hubei Key Laboratory…
- Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
- The Third Xiangya Hospital of Central South University, Research Center of National Health Ministry on Transplantation Medicine Engineering and Technology, Changsha, Hunan, China.
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Kong, F., Wang, L., Lu, Z., Zhou, J., Ye, Q., Hancock, W. W., & Xiong, Y. (2025). MEF2D regulates T-cell function via CD70-CD27 signaling and promotes immune evasion in hepatocellular carcinoma. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf228
Vancouver
Kong F, Wang L, Lu Z, Zhou J, Ye Q, Hancock WW, et al. MEF2D regulates T-cell function via CD70-CD27 signaling and promotes immune evasion in hepatocellular carcinoma. The Journal of Immunology. 2025. doi:10.1093/jimmun/vkaf228
BibTeX
@article{Kong2025,
author = {Kong, Fanhua and Wang, Liqing and Lu, Zhongshan and Zhou, Jiakang and Ye, Qifa and Hancock, Wayne W and Xiong, Yan},
title = {MEF2D regulates T-cell function via CD70-CD27 signaling and promotes immune evasion in hepatocellular carcinoma},
journal = {The Journal of Immunology},
year = {2025},
doi = {10.1093/jimmun/vkaf228}
}
EUVIMED